Skip to main content
Premium Trial:

Request an Annual Quote

Geneva Bioinformatics, Swiss Institute of Bioinformatics, AnaSpec

Premium
Geneva Bioinformatics and the Swiss Institute of Bioinformatics this week released the commercial version of Aldente, a peptide mass fingerprint tool developed by SIB’s Proteome Informatics Group. The enhanced version builds upon the existing free version of Aldente released in 2002.
 
The new version allows researchers to use the software locally, giving them the ability to upload their proprietary sequence databases in a secured environment; perform batch submission; and access results and graphically evaluate them in detail and export them in different formats.
 

 
AnaSpec last week introduced 32 new peptides for drug discovery research, including beta-amyloid A4 protein precursor; M1128, viral matrix protein; and obestatin. The company also launched three new anti-LC antibodies: Anti-MAP1-LC3 alpha (NT; Anti-MAP1-LC3 beta (NT); and Anti-MAP1-LC3 alpha/beta (IN)

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.